
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis
Yang Dong, Tian-Yang Xu, Lin Fan, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 28
Yang Dong, Tian-Yang Xu, Lin Fan, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
The functional roles of the circRNA/Wnt axis in cancer
Chen Xue, Ganglei Li, Qiuxian Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Chen Xue, Ganglei Li, Qiuxian Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis
Irina V. Bure, М. В. Немцова, Ekaterina Kuznetsova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5801-5801
Open Access | Times Cited: 96
Irina V. Bure, М. В. Немцова, Ekaterina Kuznetsova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5801-5801
Open Access | Times Cited: 96
miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses
Ahmed S. Doghish, Mohammed S. Elballal, Ola Elazazy, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154440-154440
Closed Access | Times Cited: 54
Ahmed S. Doghish, Mohammed S. Elballal, Ola Elazazy, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154440-154440
Closed Access | Times Cited: 54
A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance
Ahmed S. Doghish, Maghawry Hegazy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154442-154442
Closed Access | Times Cited: 50
Ahmed S. Doghish, Maghawry Hegazy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154442-154442
Closed Access | Times Cited: 50
Current Status and Prospects of Clinical Treatment of Osteosarcoma
Zong-Yuan Jiang, Ji‐Bin Liu, Xiaofeng Wang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 44
Zong-Yuan Jiang, Ji‐Bin Liu, Xiaofeng Wang, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 44
MicroRNA-1287-5p promotes ferroptosis of osteosarcoma cells through inhibiting GPX4
Zhengquan Xu, Lanhua Chen, Changsheng Wang, et al.
Free Radical Research (2021) Vol. 55, Iss. 11-12, pp. 1119-1129
Open Access | Times Cited: 53
Zhengquan Xu, Lanhua Chen, Changsheng Wang, et al.
Free Radical Research (2021) Vol. 55, Iss. 11-12, pp. 1119-1129
Open Access | Times Cited: 53
Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
Jianghu Zhou, Fengjun Lan, Miao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Jianghu Zhou, Fengjun Lan, Miao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Epigenomics in aortic dissection: From mechanism to therapeutics
Tao Yan, Gang Li, Yanyan Yang, et al.
Life Sciences (2023) Vol. 335, pp. 122249-122249
Closed Access | Times Cited: 13
Tao Yan, Gang Li, Yanyan Yang, et al.
Life Sciences (2023) Vol. 335, pp. 122249-122249
Closed Access | Times Cited: 13
Noncoding RNAs in osteosarcoma: Implications for drug resistance
Zhengjun Lin, Xubin Xie, Shi Yao Lu, et al.
Cancer Letters (2021) Vol. 504, pp. 91-103
Closed Access | Times Cited: 27
Zhengjun Lin, Xubin Xie, Shi Yao Lu, et al.
Cancer Letters (2021) Vol. 504, pp. 91-103
Closed Access | Times Cited: 27
Advances in the Biological Functions and Mechanisms of miRNAs in the Development of Osteosarcoma
Zihe Dong, Zhipeng Liao, Yonglin He, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 19
Zihe Dong, Zhipeng Liao, Yonglin He, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 19
MicroRNAs as the pivotal regulators of cisplatin resistance in osteosarcoma
Meysam Moghbeli
Pathology - Research and Practice (2023) Vol. 249, pp. 154743-154743
Open Access | Times Cited: 10
Meysam Moghbeli
Pathology - Research and Practice (2023) Vol. 249, pp. 154743-154743
Open Access | Times Cited: 10
Targeted inhibition of JMJD2C/MALAT1 axis compensates for the deficiency of metformin in reversing ovarian cancer platinum resistance
Linlin Li, Jialin Zhang, Huiqing Li, et al.
Life Sciences (2025), pp. 123663-123663
Closed Access
Linlin Li, Jialin Zhang, Huiqing Li, et al.
Life Sciences (2025), pp. 123663-123663
Closed Access
IOX-1 suppresses metastasis of osteosarcoma by upregulating histone H3 lysine trimethylation
Sunny Li‐Yun Chang, Chiang‐Wen Lee, Chen‐Yu Yang, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115472-115472
Open Access | Times Cited: 8
Sunny Li‐Yun Chang, Chiang‐Wen Lee, Chen‐Yu Yang, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115472-115472
Open Access | Times Cited: 8
Circular RNA_ANKIB1 accelerates chemo-resistance of osteosarcoma via binding microRNA-26b-5p and modulating enhancer of zeste homolog 2
Jinshan Tang, Gang Duan, Yunqing Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7351-7366
Open Access | Times Cited: 14
Jinshan Tang, Gang Duan, Yunqing Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7351-7366
Open Access | Times Cited: 14
Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages
Jincheng Wang, Jialu Jin, Ting Chen, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4345-4345
Open Access | Times Cited: 12
Jincheng Wang, Jialu Jin, Ting Chen, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4345-4345
Open Access | Times Cited: 12
Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
Hefen Chen, Zhujun Gong, Hong Zhou, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 2
Hefen Chen, Zhujun Gong, Hong Zhou, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 2
Correction to: microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis
Dong Yang, Tianyang Xu, Lin Fan, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 15
Dong Yang, Tianyang Xu, Lin Fan, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 15
MicroRNA-181a-5p Promotes Osteosarcoma Progression via PTEN/AKT Pathway
Chen Sun, Chi Chen, Zhen Chen, et al.
Analytical Cellular Pathology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 11
Chen Sun, Chi Chen, Zhen Chen, et al.
Analytical Cellular Pathology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 11
Targeting histone demethylases as a potential cancer therapy (Review)
Wenfei Diao, Jiabin Zheng, Yong Li, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Closed Access | Times Cited: 11
Wenfei Diao, Jiabin Zheng, Yong Li, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Closed Access | Times Cited: 11
Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma
Runyi Jiang, Shaohui He, Haiyi Gong, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 8
Runyi Jiang, Shaohui He, Haiyi Gong, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 8
RETRACTED ARTICLE: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44
Xingguang Liu, Tengda Zhao, Zhe Yuan, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Xingguang Liu, Tengda Zhao, Zhe Yuan, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
RETRACTED ARTICLE: LINC01354/microRNA-216b/KRAS Axis Promotes the Occurrence and Metastasis of Endometrial Cancer
Yan Zhang, Wei Zhao, Fei Na, et al.
Nanoscale Research Letters (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Yan Zhang, Wei Zhao, Fei Na, et al.
Nanoscale Research Letters (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Identification of genes contributing to cisplatin resistance in osteosarcoma cells
Mingzhong Xie, Haoping Dai, Qingwen Gu, et al.
FEBS Open Bio (2022) Vol. 13, Iss. 1, pp. 164-173
Open Access | Times Cited: 5
Mingzhong Xie, Haoping Dai, Qingwen Gu, et al.
FEBS Open Bio (2022) Vol. 13, Iss. 1, pp. 164-173
Open Access | Times Cited: 5
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas
Cristina López, Nikolai Schleußner, Stephan Wolf, et al.
Haematologica (2022) Vol. 108, Iss. 2, pp. 543-554
Open Access | Times Cited: 4
Cristina López, Nikolai Schleußner, Stephan Wolf, et al.
Haematologica (2022) Vol. 108, Iss. 2, pp. 543-554
Open Access | Times Cited: 4
Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review
Huanhuan Chen, Tie‐Ning Zhang, Fang‐Yuan Zhang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 4
Huanhuan Chen, Tie‐Ning Zhang, Fang‐Yuan Zhang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 4